LAV Biosciences Fund V, L.P.'s Form 4 filing
Terns Pharmaceuticals, Inc.TERN · filed Nov 28, 2022
- Accession no.
- 0001209191-22-058874
- Filed
- Nov 28, 2022, 4:56 PM ET
- Trade date
- Nov 23, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $8.25M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LAV Biosciences Fund V, L.P.CIK 0001764435 | 10% Owner |
| Oriental Spring Venture LtdCIK 0001844154 | 10% Owner |
| Hopewell Resources Holdings LtdCIK 0001844158 | 10% Owner |
| LAV Aqua LtdCIK 0001844279 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | Common Stock | SSaleDisposed | −1,000,000 | $5.50 | −$5,500,000 | 405,583 | Indirect | |
| Nov 23, 2022 | Common Stock | SSaleDisposed | −333,334 | $5.50 | −$1,833,337 | 1,059,523 | Indirect | |
| Nov 23, 2022 | Common Stock | SSaleDisposed | −166,666 | $5.50 | −$916,663 | 529,762 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.